Want to see JP:3154 full AI Analyst Report?
Medius Holdings Co., Ltd. (3154) AI Stock Analysis
Medius Holdings Co., Ltd.
(TSE/TYO:3154)
The overall score of 40 reflects significant financial risk due to deteriorating profitability and weak cash flow, compounded by bearish technical indicators and a valuation that does not fully account for the company's challenges. The balance sheet improvement provides some support, but it is insufficient to offset the negative trends.
Medius Holdings Co., Ltd. (3154) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 16.21B
- Dividend Yield
- 2.79%
- Average Volume (3M)
- 27.22K
- Price to Earnings (P/E)
- 17.2
- Beta (1Y)
- 0.56
- Revenue Growth
- 4.73%
- EPS Growth
- -31.38%
- Country
- Japan
- Employees
- 2,716
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Distribution
Medius Holdings Co., Ltd. Business Overview & Revenue Model
Company Description
Medius Holdings Co., Ltd. is a Japanese enterprise deeply embedded in the healthcare sector. The company's operations involve the distribution of a diverse range of medical devices, encompassing fundamental consumables such as syringes and gauze, as...
How the Company Makes Money
Medius Holdings primarily makes money through the sale and distribution of medical devices and related medical consumables to healthcare providers (e.g., hospitals and clinics). Revenue is generated when the company procures products from manufacture...
Medius Holdings Co., Ltd. Financial Statement Overview
Summary
Revenue growth is positive, but profitability has declined sharply (net margin 0.31%) and cash flow generation is weak, raising financial risk. The balance sheet has improved with lower leverage, but overall financial health remains poor.
Income Statement
28NegativeBalance Sheet
62PositiveCash Flow
22Negative| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 302.34B | 302.34B | 288.69B | 259.79B | 239.05B | 221.69B |
| Gross Profit | 35.00B | 35.82B | 33.30B | 31.09B | 29.31B | 27.42B |
| EBITDA | 4.33B | 4.01B | 4.77B | 3.86B | 4.27B | 3.80B |
| Net Income | 944.09M | 944.09M | 1.38B | 1.12B | 1.50B | 1.87B |
Balance Sheet | ||||||
| Total Assets | 112.59B | 112.59B | 113.54B | 115.34B | 97.73B | 93.15B |
| Cash, Cash Equivalents and Short-Term Investments | 10.05B | 10.05B | 14.33B | 13.64B | 10.33B | 9.11B |
| Total Debt | 18.39B | 18.39B | 21.89B | 24.57B | 19.70B | 17.98B |
| Total Liabilities | 91.85B | 91.85B | 93.06B | 95.60B | 79.15B | 75.84B |
| Stockholders Equity | 20.74B | 20.74B | 20.48B | 19.74B | 18.57B | 17.31B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -373.71M | 5.26B | 261.12M | 300.65M | -8.49B |
| Operating Cash Flow | 0 | 374.23M | 7.01B | 1.92B | 1.22B | -3.90B |
| Investing Cash Flow | 0 | -1.26B | -2.51B | -2.67B | -862.94M | -4.82B |
| Financing Cash Flow | 0 | -3.40B | -3.47B | 4.01B | 862.90M | 5.21B |
Medius Holdings Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3154, the sentiment is Negative. The current price of 723.00 is below the 20-day moving average (MA) of 756.75, below the 50-day MA of 777.16, and below the 200-day MA of 797.31, indicating a bearish trend. The MACD of -14.34 indicates Positive momentum. The RSI at 27.02 is Positive, neither overbought nor oversold. The STOCH value of 5.19 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3154.
Medius Holdings Co., Ltd. Peers Comparison
Overall Rating
JP:773079Outperform
JP:774772Outperform
JP:797966Neutral
JP:771660Neutral
JP:770256Neutral- JP:315440Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:7730 | 79Outperform | JPY 146.79B | 20.95 | ― | 2.79% | 10.18% | 55.86% |
| JP:7747 | 72Outperform | JPY 936.06B | 32.27 | 19.88% | 1.37% | 21.16% | 156.97% |
| JP:7979 | 66Neutral | JPY 78.82B | 12.95 | ― | 2.76% | 6.53% | 52.32% |
| JP:7716 | 60Neutral | JPY 243.75B | 103.36 | 1.89% | 2.14% | 14.87% | -55.19% |
| JP:7702 | 56Neutral | JPY 10.46B | -15.39 | ― | 3.92% | -5.34% | -152.53% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:3154 | 40Underperform | JPY 16.19B | 17.22 | ― | 2.79% | 4.73% | -31.38% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:3154 | Medius Holdings Co., Ltd. | 723.00 | -41.18 | -5.39% | |
| JP:7747 | Asahi Intecc Co | 3890.00 | 1517.63 | 63.97% | |
| JP:7716 | Nakanishi | 1442.00 | 473.50 | 48.89% | |
| JP:7702 | JMS Co., Ltd. | 441.00 | 30.85 | 7.52% | |
| JP:7730 | Mani, Inc. | 1542.00 | 122.33 | 8.62% | |
| JP:7979 | Shofu Inc. | 2162.00 | 384.85 | 21.66% |
Medius Holdings Co., Ltd. Corporate Events
Medius Holdings Sees Profit Drop but Projects Earnings Recovery in FY2027
Medius Holdings Co., Ltd., a Tokyo Prime Market-listed company, reported consolidated net sales of ¥302.3 billion for the fiscal year ended June 30, 2026, a 4.7% increase year on year, while operating profit and ordinary profit declined slightly...
Medius Holdings Announces Corrections to Previously Released Financial Results
Medius Holdings Co., Ltd., a Prime Market-listed Japanese company, has notified investors that previously released financial results contain errors that require correction. The firm has directed stakeholders to its Japanese disclosure materials for d...
Medius Holdings Names Hiroyuki Akutagawa as New President and Representative Director
Medius Holdings Co., Ltd. announced that President and Representative Director Yasuhiko Ikeya will resign from his role effective August 1, 2026, due to health reasons, and will assume the post of non-representative Chairman. The Board of Directors h...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026